Evidence map›Paper›PMID 37333343›Full record

ArticlebioRxiv : the preprint server for biology2023

Distributable, Metabolic PET Reporting of Tuberculosis.

R M Naseer Khan, Yong-Mo Ahn, Gwendolyn A Marriner, Laura E Via, Francois D'Hooge, Seung Seo Lee, Nan Yang, Falguni Basuli, Alexander G White, Jaime A Tomko and 20 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

R M Naseer KhanDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, Oxford, UK.
Yong-Mo AhnTuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research (DIR), National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH), Bethesda, MD USA.
Gwendolyn A MarrinerTuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research (DIR), National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH), Bethesda, MD USA.
Laura E ViaTuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research (DIR), National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH), Bethesda, MD USA.
Francois D'HoogeDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, Oxford, UK.
Seung Seo LeeDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, Oxford, UK.
Nan YangDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, Oxford, UK.
Falguni BasuliChemistry and Synthesis Center, NHLBI, NIH, Bethesda, MD USA.
Alexander G WhiteDepartment of Microbiology and Molecular Genetics, University of Pittsburgh.
Jaime A TomkoDepartment of Microbiology and Molecular Genetics, University of Pittsburgh.
L James FryeDepartment of Microbiology and Molecular Genetics, University of Pittsburgh.
Charles A ScangaDepartment of Microbiology and Molecular Genetics, University of Pittsburgh.
Danielle M WeinerTuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research (DIR), National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH), Bethesda, MD USA.
Michelle L SutphenTuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research (DIR), National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH), Bethesda, MD USA.
Daniel M SchimelTuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research (DIR), National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH), Bethesda, MD USA.
Emmanuel DayaoTuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research (DIR), National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH), Bethesda, MD USA.
Michaela K PiazzaTuberculosis Imaging Program, DIR, NIAID, NIH, Bethesda, MD 20892.
Felipe GomezTuberculosis Imaging Program, DIR, NIAID, NIH, Bethesda, MD 20892.
William DieckmannPositron Emission Tomography Department, Clinical Center, NIH, Bethesda, MD USA 20892.
Peter HerscovitchPositron Emission Tomography Department, Clinical Center, NIH, Bethesda, MD USA 20892.
N Scott MasonDepartment of Radiology, University of Pittsburgh.
Rolf SwensonChemistry and Synthesis Center, NHLBI, NIH, Bethesda, MD USA.
Dale O KiesewetterMolecular Tracer and Imaging Core Facility, National Institute of Biomedical Imaging and Bioengineering, NIH, Bethesda, MD 20892.
Keriann M BackusDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, Oxford, UK.
Yiqun GengDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, Oxford, UK.
Ritu RajDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, Oxford, UK.
Daniel C AnthonyLaboratory of Experimental Neuropathology, Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK.
JoAnne L FlynnDepartment of Microbiology and Molecular Genetics, University of Pittsburgh.
Clifton E BarryTuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research (DIR), National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH), Bethesda, MD USA.
Benjamin G DavisDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, Oxford, UK.

Funding

CAP: Development of a Tuberculosis-Specific PET Imaging AgentZIAAI001164 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BARRY, CLIFTON · 2012 to 2017
$1.3M
Intramural NIH HHS ZIA AI001164
6 · The paper itself

Abstract

Tuberculosis remains a large global disease burden for which treatment regimens are protracted and monitoring of disease activity difficult. Existing detection methods rely almost exclusively on bacterial culture from sputum which limits sampling to organisms on the pulmonary surface. Advances in monitoring tuberculous lesions have utilized the common glucoside [

Identifiers

PMID37333343
PMCPMC10274857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.